A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a multicenter, randomized, open-label phase II clinical trial to evaluate alprostadil liposomal injection in the prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
Epistemonikos ID: a72a9f0e4450812908b411de587befc38b7c9354
First added on: May 13, 2024